drugset / Trial / NCT00055926
CP-724,714 in Treating Patients With Metastatic Breast Cancer
Open-labelTreatment
Summary
RATIONALE: CP-724,714 may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase I trial to study the effectiveness of CP-724,714 in treating patients who have metastatic HER2-overexpressing breast cancer.
Timeline
- Start
- 2003-01
- Primary completion
- 2004-12
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CP-724,714 | Small molecule | — | Oral |